Anti-interleukin-6 therapy through application of a monogenic protein inhibitor via gene delivery-Reference-Cited by-同舟云学术

Anti-interleukin-6 therapy through application of a monogenic protein inhibitor via gene delivery

Published:2015-10-01 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Görtz Dieter,Braun Gerald S.,Maruta Yuichi,Djudjaj Sonja,van Roeyen Claudia R.,Martin Ina V.,Küster Andrea,Schmitz-Van de Leur Hildegard,Scheller Jürgen,Ostendorf Tammo,Floege Jürgen,Müller-Newen Gerhard

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep14685.pdf

Reference51 articles.

1. Taylor, P. C. & Feldmann, M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat. Rev. Rheumatol. 5, 578–82 (2009).

2. Kang, S., Tanaka, T. & Kishimoto, T. Therapeutic uses of anti-interleukin-6 receptor antibody. Int. Immunol. 27, 21–9 (2014).

3. Dinarello, C. A., Simon, A. & van der Meer, J. W. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug. Discov. 11, 633–52 (2012).

4. Choy, E. H., Kavanaugh, A. F. & Jones, S. A. The problem of choice: current biologic agents and future prospects in RA. Nat. Rev. Rheumatol. 9, 154–63 (2013).

5. Chan, A. C. & Carter, P. J. Therapeutic antibodies for autoimmunity and inflammation. Nat. Rev. Immunol. 10, 301–16 (2010).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intratumoral Delivery of Genetically Engineered Anti-IL-6 Trans-signaling Therapeutics;Molecular Biotechnology;2024-07-09

2. Alkoxide hydrolysis in-situ constructing robust trimanganese tetraoxide/graphene composite for high-performance lithium storage;Journal of Colloid and Interface Science;2021-07

3. Engineering Af1521 improves ADP-ribose binding and identification of ADP-ribosylated proteins;Nature Communications;2020-10-15

4. Thirty-Eight-Negative Kinase 1 Is a Mediator of Acute Kidney Injury in Experimental and Clinical Traumatic Hemorrhagic Shock;Frontiers in Immunology;2020-08-26

5. Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling;Leukemia;2019-03-06